Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia.

Dillon LW, Hayati S, Roloff GW, Tunc I, Pirooznia M, Mitrofanova A, Hourigan CS.

Haematologica. 2018 Aug 31. pii: haematol.2018.203133. doi: 10.3324/haematol.2018.203133. [Epub ahead of print]

2.

Sensitivity analysis of consumption cycles.

Jungeilges J, Ryazanova T, Mitrofanova A, Popova I.

Chaos. 2018 May;28(5):055905. doi: 10.1063/1.5024033.

PMID:
29857677
3.

Integrative (epi) Genomic Analysis to Predict Response to Androgen-Deprivation Therapy in Prostate Cancer.

Panja S, Hayati S, Epsi NJ, Parrott JS, Mitrofanova A.

EBioMedicine. 2018 May;31:110-121. doi: 10.1016/j.ebiom.2018.04.007. Epub 2018 Apr 12.

4.

Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation.

Chua CW, Epsi NJ, Leung EY, Xuan S, Lei M, Li BI, Bergren SK, Hibshoosh H, Mitrofanova A, Shen MM.

Elife. 2018 Jan 15;7. pii: e28768. doi: 10.7554/eLife.28768.

5.

[Extrarenal rhabdoid tumor: A review of literature and a report of cases with atypical morphology].

Mitrofanova AM, Roshchin VY, Kislyakov AN, Abramov DS, Rogozhin DV, Konovalov DM.

Arkh Patol. 2017;79(3):34-41. doi: 10.17116/patol201779334-41. Review. Russian.

PMID:
28631714
6.

A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue.

Talos F, Mitrofanova A, Bergren SK, Califano A, Shen MM.

Nat Commun. 2017 Apr 21;8:14662. doi: 10.1038/ncomms14662.

7.

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

Zou M, Toivanen R, Mitrofanova A, Floch N, Hayati S, Sun Y, Le Magnen C, Chester D, Mostaghel EA, Califano A, Rubin MA, Shen MM, Abate-Shen C.

Cancer Discov. 2017 Jul;7(7):736-749. doi: 10.1158/2159-8290.CD-16-1174. Epub 2017 Apr 14.

8.

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.

Dutta A, Panja S, Virk RK, Kim JY, Zott R, Cremers S, Golombos DM, Liu D, Mosquera JM, Mostaghel EA, Barbieri CE, Mitrofanova A, Abate-Shen C.

Eur Urol. 2017 Oct;72(4):499-506. doi: 10.1016/j.eururo.2017.03.031. Epub 2017 Apr 4.

PMID:
28385453
9.

Genetic determination of the vascular reactions in humans in response to the diving reflex.

Baranova TI, Berlov DN, Glotov OS, Korf EA, Minigalin AD, Mitrofanova AV, Ahmetov II, Glotov AS.

Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H622-H631. doi: 10.1152/ajpheart.00080.2016. Epub 2016 Dec 6.

10.

Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes.

Ahmad A, Mitrofanova A, Bielawski J, Yang Y, Marples B, Fornoni A, Zeidan YH.

FASEB J. 2017 Feb;31(2):771-780. doi: 10.1096/fj.201600618R. Epub 2016 Nov 11.

PMID:
27836988
11.

Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

Pedigo CE, Ducasa GM, Leclercq F, Sloan A, Mitrofanova A, Hashmi T, Molina-David J, Ge M, Lassenius MI, Forsblom C, Lehto M, Groop PH, Kretzler M, Eddy S, Martini S, Reich H, Wahl P, Ghiggeri G, Faul C, Burke GW 3rd, Kretz O, Huber TB, Mendez AJ, Merscher S, Fornoni A.

J Clin Invest. 2016 Sep 1;126(9):3336-50. doi: 10.1172/JCI85939. Epub 2016 Aug 2.

12.

Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation.

Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate-Shen C.

Science. 2016 Jun 24;352(6293):1576-80. doi: 10.1126/science.aad9512.

13.

Nephrin Contributes to Insulin Secretion and Affects Mammalian Target of Rapamycin Signaling Independently of Insulin Receptor.

Villarreal R, Mitrofanova A, Maiguel D, Morales X, Jeon J, Grahammer F, Leibiger IB, Guzman J, Fachado A, Yoo TH, Busher Katin A, Gellermann J, Merscher S, Burke GW, Berggren PO, Oh J, Huber TB, Fornoni A.

J Am Soc Nephrol. 2016 Apr;27(4):1029-41. doi: 10.1681/ASN.2015020210. Epub 2015 Sep 23.

14.

Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models.

Mitrofanova A, Aytes A, Zou M, Shen MM, Abate-Shen C, Califano A.

Cell Rep. 2015 Sep 29;12(12):2060-71. doi: 10.1016/j.celrep.2015.08.051. Epub 2015 Sep 17.

15.

BK virus nephropathy in a pediatric patient after hematopoietic stem cell transplantation.

Aksenova M, Tsetlina V, Gutovskaya E, Mitrofanova A, Balashov D, Maschan A.

Pediatr Transplant. 2015 Feb;19(1):E29-32. doi: 10.1111/petr.12411. Epub 2014 Dec 7.

PMID:
25484248
16.

Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.

Yoo TH, Pedigo CE, Guzman J, Correa-Medina M, Wei C, Villarreal R, Mitrofanova A, Leclercq F, Faul C, Li J, Kretzler M, Nelson RG, Lehto M, Forsblom C, Groop PH, Reiser J, Burke GW, Fornoni A, Merscher S.

J Am Soc Nephrol. 2015 Jan;26(1):133-47. doi: 10.1681/ASN.2013111213. Epub 2014 Jun 12.

17.

Malignant rhabdoid tumor of the liver presented with initial tumor rupture.

Kachanov D, Teleshova M, Kim E, Dobrenkov K, Moiseenko R, Usychkina A, Filin A, Semenkov A, Mitrofanova A, Konovalov D, Shamanskaya T, Novichkova G, Varfolomeeva S.

Cancer Genet. 2014 Sep;207(9):412-4. doi: 10.1016/j.cancergen.2014.04.006. Epub 2014 Apr 21.

PMID:
24894493
18.

Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy.

Aytes A, Mitrofanova A, Lefebvre C, Alvarez MJ, Castillo-Martin M, Zheng T, Eastham JA, Gopalan A, Pienta KJ, Shen MM, Califano A, Abate-Shen C.

Cancer Cell. 2014 May 12;25(5):638-651. doi: 10.1016/j.ccr.2014.03.017.

19.

[Atypical teratoid/rhabdoid tumors of childhood].

Mitrofanova AM, Konovalov DM, Kisliakov AN, Roshchin VIu, Abramov DS.

Arkh Patol. 2013 Sep-Oct;75(5):36-42. Russian.

PMID:
24341231
20.

Structural determinants of the insulin receptor-related receptor activation by alkali.

Deyev IE, Mitrofanova AV, Zhevlenev ES, Radionov N, Berchatova AA, Popova NV, Serova OV, Petrenko AG.

J Biol Chem. 2013 Nov 22;288(47):33884-93. doi: 10.1074/jbc.M113.483172. Epub 2013 Oct 11.

21.

Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.

Guzman J, Jauregui AN, Merscher-Gomez S, Maiguel D, Muresan C, Mitrofanova A, Diez-Sampedro A, Szust J, Yoo TH, Villarreal R, Pedigo C, Molano RD, Johnson K, Kahn B, Hartleben B, Huber TB, Saha J, Burke GW 3rd, Abel ED, Brosius FC, Fornoni A.

Diabetes. 2014 Feb;63(2):701-14. doi: 10.2337/db13-0752. Epub 2013 Oct 7.

22.

ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.

Aytes A, Mitrofanova A, Kinkade CW, Lefebvre C, Lei M, Phelan V, LeKaye HC, Koutcher JA, Cardiff RD, Califano A, Shen MM, Abate-Shen C.

Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):E3506-15. doi: 10.1073/pnas.1303558110. Epub 2013 Aug 5.

23.

Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity.

Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, Shen MM.

Nat Cell Biol. 2013 Mar;15(3):274-83. doi: 10.1038/ncb2697. Epub 2013 Feb 24.

24.

B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer.

Wang J, Kobayashi T, Floc'h N, Kinkade CW, Aytes A, Dankort D, Lefebvre C, Mitrofanova A, Cardiff RD, McMahon M, Califano A, Shen MM, Abate-Shen C.

Cancer Res. 2012 Sep 15;72(18):4765-76. Epub 2012 Jul 25.

25.

Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model.

Floc'h N, Kinkade CW, Kobayashi T, Aytes A, Lefebvre C, Mitrofanova A, Cardiff RD, Califano A, Shen MM, Abate-Shen C.

Cancer Res. 2012 Sep 1;72(17):4483-93. doi: 10.1158/0008-5472.CAN-12-0283. Epub 2012 Jul 19.

26.

Prediction of protein functions with gene ontology and interspecies protein homology data.

Mitrofanova A, Pavlovic V, Mishra B.

IEEE/ACM Trans Comput Biol Bioinform. 2011 May-Jun;8(3):775-84. doi: 10.1109/TCBB.2010.15.

PMID:
21393654
27.

[Dynamics of parameters of energy metabolism at adaptation to diving in human].

Baranova TI, Kovalenko RI, Mitrofanova AV, Ianvareva IN.

Zh Evol Biokhim Fiziol. 2010 Sep-Oct;46(5):411-20. Russian.

PMID:
21061652
28.

On a novel coalescent model for genome-wide evolution of copy number variations.

Mitrofanova A, Mishra B.

Int J Data Min Bioinform. 2010;4(3):300-15.

PMID:
20681481
29.

Predicting malaria interactome classifications from time-course transcriptomic data along the intraerythrocytic developmental cycle.

Mitrofanova A, Kleinberg S, Carlton J, Kasif S, Mishra B.

Artif Intell Med. 2010 Jul;49(3):167-76. doi: 10.1016/j.artmed.2010.04.013. Epub 2010 Jun 26.

PMID:
20580212
30.

Efficient and robust prediction algorithms for protein complexes using Gomory-Hu trees.

Mitrofanova A, Farach-Colton M, Mishra B.

Pac Symp Biocomput. 2009:215-26.

31.

[Oksidevit in the combined prevention of rickets in premature children].

Strukov VI, Radchenko LG, Krugliakova RP, Mitrofanova AV, Kosolapova NI.

Pediatriia. 1987;(9):76-8. Russian. No abstract available.

PMID:
3501105
32.

[Effect of rations containing fluorine ion on biochemical and hematological indices of body status].

Lykova AS, Mitrofanova AI, Skachkov MA.

Vopr Pitan. 1981 Nov-Dec;(6):46-7. Russian.

PMID:
6275610
33.

[Medico-toxicological characteristics of diethylene glycol ethers (carbitols) applicable to air pollution control].

Krotov IuA, Lykova AS, Skachkov MA, Sachkov AV, Mitrofanova AI.

Gig Sanit. 1981 Feb;(2):14-7. Russian. No abstract available.

PMID:
7215828
34.

[Materials toward setting health standards for monoisopropyl and monobutyl esters of ethylene glycol in atmospheric air].

Lykova AS, Skachkov MA, Mitrofanova AI, Davydova MP, Saparmamedov ES.

Gig Sanit. 1976 Nov;(11):7-11. Russian. No abstract available.

PMID:
1017622
35.

[Technic of capsular arthroplasty in congenital dislocation of the hip].

Mitrofanova AV.

Ortop Travmatol Protez. 1967 Feb;28(2):62-6. Russian. No abstract available.

PMID:
5620312

Supplemental Content

Loading ...
Support Center